Relation between alternatively spliced tissue factor and tumor

doi:10.3760/cma.j.issn.1673422X.2015.05.011

Abstract

ZHAO Lin-Yan, JIANG Bo, ZHANG Ri. Relation between alternatively spliced tissue factor and tumor[J]. Journal of International Oncology, 2015, 42(5): 361-363.

［1］刘育成，陈群. 组织因子及其在凝血、非凝血功能中的研究进展［J］. 医学信息, 2011, 24(4): 24832485. ［2］ Mackman N, Morrissey JH, Fowler B, et al. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade［J］. Biochemistry, 1989, 28(4):17551762. ［3］ Kocaturk B, Versteeg HH. Tissue factor isoforms in cancer and coagulation: May the best isoform win［J］. Thromb Res, 2012, 129Suppl: S6975. ［4］ Chandradas S, Deikus G, Tardos JG, et al. Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells［J］. J Leukoc Biol, 2010, 87(1):147152. ［5］ Meseguer S, Mudduluru G, Escamilla JM, et al. MicroRNAs10a and 210b contribute to retinoic acidinduced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF)［J］. J Biol Chem, 2011, 286(6):41504164. ［6］ Wang N, Zhu M, Tsao SW, et al. MiR23amediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma［J］. Mol Cancer, 2013, 12(1):119. ［7］ Zhang X, Yu H, Lou JR, et al. MicroRNA19(miR19)regulate tissue factor expression in breast cancer cells［J］. J Biol Chem, 2011, 286(2):14291435. ［8］ Chuang TD, Luo X, Panda H, et al. miR93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL8［J］. Mol Endocrinol, 2012, 26(6):10281042. ［9］ Leppert U, Eisenreich A. The role of tissue factor isoforms in cancer biology［J］. Int J Cancer, 2015, 137(3):497503. ［10］ Eisenreich A, Boltzen U, Malz R, et al. Overexpression of alternatively spliced tissue factor induces the proangiogenic properties of murine cardiomyocytic HL1 cells［J］. Circ J, 2011, 75(5):12351242. ［11］ van den Berg YW, Osanto S, Reitsma PH, et al. The relationship between tissue factor and cancer progression: insights from bench and bedside［J］. Blood, 2012, 119 (4):924932. ［12］ Mackman N, Davis GE. Blood coagulation and blood vessel development: is tissue factor the missing link? ［J］. Arterioscler Thromb Vasc Biol, 2011, 31(11):23642366. ［13］ nlü B, Versteeg HH. Effects of tumorexpressed coagulation factors on cancer progression and venous thrombosis: is there a key factor? ［J］. Thromb Res, 2014, 133Suppl 2:S7684. ［14］ Eisenreich A, Rauch U. Regulation and differential role of the tissue factor isoforms in cardiovascular biology［J］. Trends Cardiovasc Med, 2010, 20(6): 199203. ［15］ Eisenreich A, Zakrzewicz A, Huber K, et al. Regulation of proangiogenic tissue factor expression in hypoxiainduced human lung cancer cells［J］. Oncol Rep, 2013, 30(1):462470. ［16］ Debdab M, Carreaux F, Renault S, et al. Leucettines, a class of potent inhibitors of cdc2like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative preRNA splicing［J］. J Med Chem, 2011, 54(12):41724186. ［17］ Giannarelli C, Alique M, Rodriguez DT, et al. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of HIF1a and VEGF signaling［J］. Circulation, 2014, 130(15):12741286. ［18］ Rollin J, Regina S, Gruel Y. Tumor expression of alternatively spliced tissue factor is a prognostic marker in nonsmall cell lung cancer［J］. J Thromb Haemost, 2010, 8(3):607610. ［19］ Srinivasan R, Ozhegov E, van den Berg YW, et al. Splice variants of tissue factor promote monocyteendothelial interactions by triggering the expression of cell adhesion molecules via integrinmediated signaling［J］. J Thromb Haemost, 2011, 9(10):20872096. ［20］ Srinivasan R, Bogdanov VY. Splice variants of Tissue Factor and integrinmediated signaling［J］. Thromb Res, 2012, 129Suppl 2:S3437. ［21］ Kocatürk B, Van den Berg YW, Tieken C, et al. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrindependent manner［J］. Proc Natl Acad Sci USA, 2013, 110(28):1151711522. ［22］ Unruh D, Turner K, Srinivasan R, et al. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma［J］. Int J Cancer, 2014, 134(1):920. ［23］ Rollin J, Regina S, Gruel Y. Tumor expression of alternatively spliced tissue factor is a prognostic marker in nonsmall cell lung cancer［J］. J Thromb Haemost, 2010, 8(3):607610.

Relation between alternatively spliced tissue factor and tumor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments